Myelodysplasia Journal Article


Authors: Heaney, M. L.; Golde, D. W.
Article Title: Myelodysplasia
Keywords: cancer chemotherapy; acute granulocytic leukemia; clinical feature; clinical trial; pathogenesis; review; disease classification; side effect; antineoplastic agents; pathophysiology; alpha interferon; cytarabine; topotecan; antineoplastic agent; polymerase chain reaction; cancer immunotherapy; erythropoietin; granulocyte macrophage colony stimulating factor; cytogenetics; hematopoietic stem cell transplantation; chronic myeloid leukemia; cell transformation, neoplastic; monoclonal antibody; cytokine; hla matching; myelodysplastic syndrome; fluorescence in situ hybridization; immunotherapy; hematopoietic stem cells; interleukin 6; 5 aza 2' deoxycytidine; anthracycline; malignant transformation; granulocyte colony stimulating factor; cyclosporin; hla antigen; retinoid; amifostine; myelodysplastic syndromes; thymocyte antibody; fluid retention; thrombopoietin; myelodysplasia; interleukin 11; hexamethylenebisacetamide; humans; human; priority journal; colecalciferol derivative
Journal Title: New England Journal of Medicine
Volume: 340
Issue: 21
ISSN: 0028-4793
Publisher: Massachusetts Medical Society  
Date Published: 1999-05-27
Start Page: 1649
End Page: 1660
Language: English
DOI: 10.1056/nejm199905273402107
PUBMED: 10341278
PROVIDER: scopus
DOI/URL:
Notes: Review -- Export Date: 16 August 2016 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Mark L Heaney
    94 Heaney
  2. David Golde
    127 Golde